Doxycycline and Seebri drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Doxycycline (doxycycline hyclate) and Seebri (glycopyrrolate). Common drug interactions include abdominal pain among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Doxycycline and Seebri. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Doxycycline?

Doxycycline has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 60,866 Doxycycline users. Check the latest studies of Doxycycline.

What is Seebri?

Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.



On Jul, 16, 2026

36 people who take Doxycycline and Seebri together, and have interactions are studied.

Doxycycline and Seebri drug interactions.

What are the common drug interactions of Doxycycline and Seebri, by gender? *:

female:

  1. Abdominal pain
  2. Abdominal discomfort
  3. Asthma
  4. Dyspnoea (difficult or laboured respiration)
  5. Respiration (transport of oxygen from the outside air to the cells within tissues)
  6. Breath sounds
  7. Bronchial hyperreactivity
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cardiac disorder
  10. Cardiomyopathy (weakening of the heart muscle)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Asthma
  3. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Photosensitivity reaction
  6. Skin hyperpigmentation (disorders affect the colour of your skin)
  7. Sunburn
  8. Acute hepatic failure
  9. Abnormal weight gain
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the common drug interactions of Doxycycline and Seebri, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Acute hepatic failure
  4. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  5. Pancreatitis acute (sudden inflammation of pancreas)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Asthma
  3. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Abdominal pain
  6. Dry mouth
  7. Photosensitivity reaction
  8. Respiration (transport of oxygen from the outside air to the cells within tissues)
  9. Skin hyperpigmentation (disorders affect the colour of your skin)
  10. Sunburn

What are the existing conditions these people have? *

  1. Asthma: 9 people, 25.00%
  2. Ill-Defined Disorder: 6 people, 16.67%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 13.89%
  4. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 4 people, 11.11%
  5. Oedema (fluid collection in tissue): 4 people, 11.11%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 11.11%
  7. Psoriasis (immune-mediated disease that affects the skin): 3 people, 8.33%
  8. Dry Skin: 3 people, 8.33%
  9. Pneumonia: 2 people, 5.56%
  10. Hiv Infection: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Doxycycline and Seebri?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Doxycycline and Seebri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Doxycycline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Seebri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Doxycycline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Seebri and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on doxycycline hyclate and glycopyrrolate (the active ingredients of Doxycycline and Seebri, respectively), and Doxycycline and Seebri (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: